Mark D. Hylarides

Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity

Donald B. Axworthy, J. M. Reno, Mark D. Hylarides et al. · Proceedings of the National Academy of Sciences · 2000 · 230 citations · Full text

Colon Cancer Xenografts, Immunology, 600-800 Microci +17

Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer.

D. Scott Wilbur, S. W. HADLEY, Mark D. Hylarides et al. · PubMed · 1989 · 172 citations

Immunocytochemical Technique, Engineering, Separate Anti-melanoma Antibodies +21

Melanoma Therapy via Peptide-Targeted α-Radiation

Yubin Miao, Mark D. Hylarides, Darrell R. Fisher et al. · Clinical Cancer Research · 2005 · 133 citations · Full text

Anti-CD45 radioimmunotherapy using 211At with bone marrow transplantation prolongs survival in a disseminated murine leukemia model

Johnnie J. Orozco, Tom Bäck, Aimee L. Kenoyer et al. · Blood · 2013 · 69 citations · Full text

Astatine-211 conjugated to an anti-CD20 monoclonal antibody eradicates disseminated B-cell lymphoma in a mouse model

Damian J. Green, Mazyar Shadman, Jon C. Jones et al. · Blood · 2015 · 63 citations · Full text